Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Plant Physiology|July 5, 2005
Identification of a gene in the process of being lost from the genus AgrostisHuaijun Michael Li, David Rotter, Stacy A Bonos, et al.Plant Disease|February 9, 2019
Molecular Analysis of Turfgrass Rusts Reveals the Widespread Distribution of Puccinia coronata as a Pathogen of Kentucky Bluegrass in the United StatesLisa A Beirn, Melinda Moy, William A Meyer, et al.Journal of Public Health Management and Practice : JPHMP|July 22, 2022
Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United StatesRobert J Wong, Harvey W Kaufman, Justin K Niles, et al.MMWR. Morbidity and Mortality Weekly Report|June 29, 2023
Hepatitis C Virus Clearance Cascade - United States, 2013-2022Carolyn Wester, Ademola Osinubi, Harvey W Kaufman, et al.Journal of Viral Hepatitis|April 29, 2025
Epidemiological Burden of Hepatitis Delta Virus in the United StatesElizabeth M Marlowe, Brooke E Swanson, Susan E Realegeno, et al.Microbiology Spectrum|July 28, 2021
Retrospective Performance Analyses of over Two Million U.S. QuantiFERON Blood Sample ResultsCaixia Bi, Richard B Clark, Ronald Master, et al.The Journal of Applied Laboratory Medicine|February 22, 2024
Nucleocapsid and Spike Protein-Based Anti-SARS-CoV-2 Assay Performance in the Minority and Rural Coronavirus Insights Study: Characteristics of Socioeconomically Disadvantaged Populations with Health DisparitiesRobert H Christenson, Shantoy Hansel, Dora II'yasova, et al.Pediatrics|June 4, 2008
Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapyCaroline J Chantry, Michael D Hughes, Carmelita Alvero, et al.The Journal of Infectious Diseases|August 4, 2012
Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected childrenAdriana Weinberg, Lin-Ye Song, Alfred Saah, et al.Plos One|January 8, 2025
Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022Anna Bratcher, Jefferson M Jones, William A Meyer, et al.Pageof 8